Gender, Histology, and Time of Diagnosis Are Important Factors for Prognosis: Analysis of 1499 Never-Smokers with Advanced Non-small Cell Lung Cancer in Japan

Sun, 2007, Lung cancer in never smokers—a different disease, Nat Rev Cancer, 7, 778, 10.1038/nrc2190 Subramanian, 2008, Molecular genetics of lung cancer in people who have never smoked, Lancet Oncol, 9, 676, 10.1016/S1470-2045(08)70174-8 Parkin, 2005, Global cancer statistics, 2002, CA Cancer J Clin, 55, 74, 10.3322/canjclin.55.2.74 Fukuoka, 2003, Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer (The IDEAL 1 Trial) [corrected], J Clin Oncol, 21, 2237, 10.1200/JCO.2003.10.038 Kris, 2003, Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer: a randomized trial, JAMA, 290, 2149, 10.1001/jama.290.16.2149 Shigematsu, 2005, Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers, J Natl Cancer Inst, 97, 339, 10.1093/jnci/dji055 Lynch, 2004, Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib, N Engl J Med, 350, 2129, 10.1056/NEJMoa040938 Zell, 2005, Epidemiology of bronchioloalveolar carcinoma: improvement in survival after release of the 1999 WHO classification of lung tumors, J Clin Oncol, 23, 8396, 10.1200/JCO.2005.03.0312 Tsao, 2006, Smoking affects treatment outcome in patients with advanced nonsmall cell lung cancer, Cancer, 106, 2428, 10.1002/cncr.21884 Toh, 2006, Never-smokers with lung cancer: epidemiologic evidence of a distinct disease entity, J Clin Oncol, 24, 2245, 10.1200/JCO.2005.04.8033 Nordquist, 2004, Improved survival in never-smokers vs current smokers with primary adenocarcinoma of the lung, Chest, 126, 347, 10.1378/chest.126.2.347 Mok, 2009, Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma, N Engl J Med, 361, 947, 10.1056/NEJMoa0810699 1999 UICC, 1997, TNM classification of malignant tumours, 91 Bryant, 2007, Differences in epidemiology, histology, and survival between cigarette smokers and never-smokers who develop non-small cell lung cancer, Chest, 132, 185, 10.1378/chest.07-0442 Subramanian, 2007, Presentation and stage-specific outcomes of lifelong never-smokers with non-small cell lung cancer (NSCLC), J Thorac Oncol, 2, 827, 10.1097/JTO.0b013e318145af79 Wisnivesky, 2007, Sex differences in lung cancer survival: do tumors behave differently in elderly women?, J Clin Oncol, 25, 1705, 10.1200/JCO.2006.08.1455 Tomizawa, 2005, Clinicopathologic significance of the mutations of the epidermal growth factor receptor gene in patients with non-small cell lung cancer, Clin Cancer Res, 11, 6816, 10.1158/1078-0432.CCR-05-0441 Toyooka, 2006, Mutational and epigenetic evidence for independent pathways for lung adenocarcinomas arising in smokers and never smokers, Cancer Res, 66, 1371, 10.1158/0008-5472.CAN-05-2625 Takano, 2008, EGFR mutations predict survival benefit from gefitinib in patients with advanced lung adenocarcinoma: a historical comparison of patients treated before and after gefitinib approval in Japan, J Clin Oncol, 26, 5589, 10.1200/JCO.2008.16.7254 Kurahashi, 2008, Passive smoking and lung cancer in Japanese non-smoking women: a prospective study, Int J Cancer, 122, 653, 10.1002/ijc.23116 Cheng, 2007, Human papillomavirus 16/18 E6 oncoprotein is expressed in lung cancer and related with p53 inactivation, Cancer Res, 67, 10686, 10.1158/0008-5472.CAN-07-1461 Toh, 2004, The impact of smoking status on the behavior and survival outcome of patients with advanced non-small cell lung cancer: a retrospective analysis, Chest, 126, 1750, 10.1378/chest.126.6.1750 Toyooka, 2007, The impact of sex and smoking status on the mutational spectrum of epidermal growth factor receptor gene in non small cell lung cancer, Clin Cancer Res, 13, 5763, 10.1158/1078-0432.CCR-07-0216